Opiate Partial Agonists
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
4 ingredients · 15 matching product records. Ontario extract of September 22, 2026.
| Ingredient / brands | Strengths and forms | Ontario listings | Browse |
|---|---|---|---|
| BUPRENORPHINESublocade | 100 mg/0.5 mL Inj Sol- 0.5mL Pref Syr; 300 mg/1.5 mL Inj Sol- 1.5mL Pref Syr | General benefit | View 2 products |
| BUPRENORPHINE & NALOXONESuboxone, PMS-Buprenorphine-Naloxone, Act Buprenorphine/Naloxone | 2 mg & 0.5 mg SL Tab; 8 mg & 2 mg SL Tab; 2 mg & 0.5 mg Soluble Film; 4 mg & 1 mg Soluble Film 2 more forms in product list | General benefit | View 10 products |
| BUPRENORPHINE HYDROCHLORIDEProbuphine | 80 mg Subdermal Implant-Kit Pk | Limited Use, codes 578 | View 1 product |
| BUTORPHANOL TARTRATEStadol NS, Butorphanol Nasal Spray | 10 mg/mL Nas Sp-2.5mL Pk | Off-Formulary Interchangeable, not an ODB benefit | View 2 products |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-09-22.xml, extract 2026-09-22. Ontario class index: formulary-ed43-front-matter.txt, Part V.
28:08:12 Opiate Partial Agonists.